Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone
Clinical trial NCT03116295 · COMPLETED
Trial details
- NCT number
- NCT03116295
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2017-08-28
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.